Discrimination of intranasal cocaine

Citation
Kj. Schuh et al., Discrimination of intranasal cocaine, BEHAV PHARM, 11(6), 2000, pp. 511-515
Citations number
3
Categorie Soggetti
Neurosciences & Behavoir
Journal title
BEHAVIOURAL PHARMACOLOGY
ISSN journal
09558810 → ACNP
Volume
11
Issue
6
Year of publication
2000
Pages
511 - 515
Database
ISI
SICI code
0955-8810(200009)11:6<511:DOIC>2.0.ZU;2-I
Abstract
In the development of medications for the treatment of cocaine abuse, the d rug discrimination paradigm can be used to identify medications that can at tenuate the discriminative stimulus effects of cocaine. To ascertain that p articipants are basing the discrimination on the drug's central effects, th is paradigm requires that the drug and placebo administrations do not produ ce any peripheral effects on which the discrimination can be based. This st udy examined whether intranasal cocaine (50 mg) can be discriminated from p lacebo (46 mg lactose +4 mg cocaine), how quickly this discrimination can b e made, and whether pretreatment with intranasal benzocaine can affect this discrimination. Results showed that subjects were generally able to discri minate the drug conditions correctly 15 s after administration, and this wa s unaffected by benzocaine. These results suggest that subjects base the di scrimination on peripheral drug effects (e.g. taste) that are not affected by anaesthesia of the nasal passage, and that the intranasal route of cocai ne administration is unlikely to be feasible with a drug discrimination par adigm. (C) 2000 Lippincott Williams & Wilkins.